

Menlo Park, California-based Synthekine Inc., an engineered cytokine therapeutics company, has raised $82 million in Series A financing. Canaan Partners, Samsara BioCapital and The Column Group led the round.
Source: Press Release
Menlo Park, California-based Synthekine Inc., an engineered cytokine therapeutics company, has raised $82 million in Series A financing.
Menlo Park, California-based Synthekine Inc., an engineered cytokine therapeutics company, has raised $82 million in Series A financing. Canaan Partners, Samsara BioCapital and The Column Group led the round.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination